Search Results - "Glick, Stanley D"

Refine Results
  1. 1

    α3β4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo by McCallum, Sarah E., Cowe, Matthew A., Lewis, Samuel W., Glick, Stanley D.

    Published in Neuropharmacology (01-09-2012)
    “…Habenulo-interpeduncular nicotinic receptors, particularly those containing α3, β4 and α5 subunits, have recently been implicated in the reinforcing effects of…”
    Get full text
    Journal Article
  2. 2

    Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats by SHOBLOCK, James R, SULLIVAN, Eric B, MAISONNEUVE, Isabelle M, GLICK, Stanley D

    Published in Psychopharmacologia (01-02-2003)
    “…Methamphetamine (METH) and amphetamine (AMPH) are both abused psychostimulants. Although METH is generally accepted to be more addictive and potent than its…”
    Get full text
    Journal Article
  3. 3

    Effects of 18-methoxycoronaridine on ghrelin-induced increases in sucrose intake and accumbal dopamine overflow in female rats by McCallum, Sarah E., Taraschenko, Olga D., Hathaway, Ethan R., Vincent, Melanie Y., Glick, Stanley D.

    Published in Psychopharmacologia (01-05-2011)
    “…Rationale 18-Methoxycoronaridine (18-MC), a selective antagonist of α3β4 nicotinic receptors, has been previously shown, in rats, to reduce the…”
    Get full text
    Journal Article
  4. 4

    18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats by Glick, Stanley D., Ramirez, Ruby L., Livi, Jacklyn M., Maisonneuve, Isabelle M.

    Published in European journal of pharmacology (10-05-2006)
    “…The novel iboga alkaloid congener 18-methoxycoronaridine (18-MC) is a putative anti-addictive agent that has been shown, in rats, to decrease the…”
    Get full text
    Journal Article
  5. 5

    Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on nicotine self-administration by Glick, Stanley D., Sell, Elizabeth M., McCallum, Sarah E., Maisonneuve, Isabelle M.

    Published in European journal of pharmacology (01-11-2011)
    “…18-Methoxycoronaridine (18-MC), a putative anti-addictive agent, has been shown to decrease the self-administration of several drugs of abuse in rats. 18-MC is…”
    Get full text
    Journal Article
  6. 6

    Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite by Carlson, Jeffrey N, Haskew, Rene, Wacker, Jennifer, Maisonneuve, Isabelle M, Glick, Stanley D, Jerussi, Thomas P

    Published in European journal of pharmacology (01-03-2001)
    “…We evaluated racemic zopiclone, its ( S)- and ( R)-enantiomers and a metabolite, ( S)-desmethylzopiclone, for their actions on locomotor activity, rotarod…”
    Get full text
    Journal Article
  7. 7

    Comparative effects of dextromethorphan and dextrorphan on morphine, methamphetamine, and nicotine self-administration in rats by Glick, Stanley D, Maisonneuve, Isabelle M, Dickinson, Heather A, Kitchen, Barbara A

    Published in European journal of pharmacology (22-06-2001)
    “…The effects of dextromethorphan and its metabolite dextrorphan on morphine, methamphetamine and nicotine self-administration and on responding for a nondrug…”
    Get full text
    Journal Article
  8. 8

    New Medications for Drug Abuse

    Published 01-01-2000
    “…Major topics covered at the converence were the following: New approaches to the treatment of pain; Bridging the gap between addicts and animal models:…”
    Get full text
    eBook
  9. 9

    Cannabinoid receptors mediate methamphetamine induction of high frequency gamma oscillations in the nucleus accumbens by Morra, Joshua T., Glick, Stanley D., Cheer, Joseph F.

    Published in Neuropharmacology (01-09-2012)
    “…Patients suffering from amphetamine-induced psychosis display repetitive behaviors, partially alleviated by antipsychotics, which are reminiscent of rodent…”
    Get full text
    Journal Article
  10. 10

    Neural Encoding of Psychomotor Activation in the Nucleus Accumbens Core, But Not the Shell, Requires Cannabinoid Receptor Signaling by Morra, Joshua T, Glick, Stanley D, Cheer, Joseph F

    Published in The Journal of neuroscience (07-04-2010)
    “…The current study aimed to further elucidate the role of endocannabinoid signaling in methamphetamine-induced psychomotor activation. Rats were treated with…”
    Get full text
    Journal Article
  11. 11

    Sex differences in high fat-induced obesity in rats: Effects of 18-methoxycoronaridine by Taraschenko, Olga D, Maisonneuve, Isabelle M, Glick, Stanley D

    Published in Physiology & behavior (01-06-2011)
    “…Abstract Evidence suggests that the development of diet-induced obesity in males and females might be mediated by distinct mechanisms, warranting different…”
    Get full text
    Journal Article
  12. 12

    Brain regions mediating α3β4 nicotinic antagonist effects of 18-MC on methamphetamine and sucrose self-administration by Glick, Stanley D., Sell, Elizabeth M., Maisonneuve, Isabelle M.

    Published in European journal of pharmacology (03-12-2008)
    “…The novel iboga alkaloid congener 18-methoxycoronaridine (18-MC) is a putative anti-addictive agent that has been shown, in rats, to decrease the…”
    Get full text
    Journal Article
  13. 13

    Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia by Brady, Anne Marie, McCallum, Sarah E., Glick, Stanley D., O’Donnell, Patricio

    Published in Psychopharmacologia (01-10-2008)
    “…Rationale Substance abuse is more prevalent among patients with schizophrenia than in the general population. The considerable overlap in neurobiological…”
    Get full text
    Journal Article
  14. 14

    18-Methoxycoronaridine blocks acquisition but enhances reinstatement of a cocaine place preference by McCallum, Sarah E., Glick, Stanley D.

    Published in Neuroscience letters (17-07-2009)
    “…The iboga alkaloid congener, 18-methoxycoronaridine (18-MC), decreases self-administration of multiple drugs of abuse. Here, in a biased procedure, we…”
    Get full text
    Journal Article
  15. 15

    Noribogaine, but not 18-MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self-administration by Carnicella, Sebastien, He, Dao-Yao, Yowell, Quinn V., Glick, Stanley D, Ron, Dorit

    Published in Addiction biology (01-10-2010)
    “…ABSTRACT Ibogaine is a naturally occurring alkaloid that has been reported to decrease various adverse phenotypes associated with exposure to drugs of abuse…”
    Get full text
    Journal Article
  16. 16

    Metabolism of 18-Methoxycoronaridine, an Ibogaine Analog, to 18-Hydroxycoronaridine by Genetically Variable CYP2C19 by WENJIANG ZHANG, RAMAMOORTHY, Yamini, TYNDALE, Rachel F, GLICK, Stanley D, MAISONNEUVE, Isabelle M, KUEHNE, Martin E, SELLERS, Edward M

    Published in Drug metabolism and disposition (01-06-2002)
    “…18-Methoxycoronaridine, a newly developed ibogaine analog, has been reported to decrease the self-administration of morphine, cocaine, ethanol, and nicotine…”
    Get full text
    Journal Article
  17. 17

    18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens by Taraschenko, Olga D., Shulan, Joseph M., Maisonneuve, Isabelle M., Glick, Stanley D.

    Published in Synapse (New York, N.Y.) (01-07-2007)
    “…18‐Methoxycoronaridine (18‐MC), a novel iboga alkaloid congener, is a potential treatment for drug addiction. 18‐MC has been shown to decrease…”
    Get full text
    Journal Article
  18. 18

    Antagonism of α3β4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration by Glick, Stanley D, Maisonneuve, Isabelle M, Kitchen, Barbara A, Fleck, Mark W

    Published in European journal of pharmacology (01-03-2002)
    “…The iboga alkaloid ibogaine and the novel iboga alkaloid congener 18-methoxycoronaridine are putative anti-addictive agents. Using patch–clamp methodology, the…”
    Get full text
    Journal Article
  19. 19

    Modulation of nicotine self-administration in rats by combination therapy with agents blocking α3β4 nicotinic receptors by Glick, Stanley D, Maisonneuve, Isabelle M, Kitchen, Barbara A

    Published in European journal of pharmacology (19-07-2002)
    “…18-Methoxycoronaridine, a novel iboga alkaloid congener that decreases drug self-administration in several animal models, may be a potential treatment for…”
    Get full text
    Journal Article
  20. 20